Form 4 for CADL Candel Therapeutics, Inc.
Accepted 2025-02-13 00:00:00 ET · period of report 2025-02-10 · accession 0001873919-25-000001 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-02-13 | 2025-02-10 | CADL | Aguilar-Cordova Estuardo | 10% | D - Sale to Iss | $8.61 | -31.3K | 60.0K | -34% | -$269.8K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | CADL | 2025-02-10 | D | D | 31,335 | $8.61 | 60,000 | D | — | — | (F1) Shares of common stock held jointly with spouse |